Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Study Identifier
P12-764
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Protocol and Statistical Analysis Plan
Available Language(s): English
Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Axial Spondyloarthritis (axSpA)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    16 - 99 Years

    Protocol Summary

    This study of adalimumab (Humira) will be conducted to clarify the following with regard to the treatment of ankylosing spondylitis with this drug:

    • Unknown adverse drug reactions (especially important adverse drug reactions)
    • Incidence and conditions of occurrence of adverse reactions in the clinical setting
    • Factors that may affect the safety and effectiveness of Humira

    Study Locations

    Location
    Status
    Location
    Nagoya City University Hospital
    Nagoya, Aichi-ken, Japan, 467-8602
    Status
    Not applicable
    Location
    Kurume University Hospital
    Kurume-shi, Fukuoka, Japan, 830-0011
    Status
    Not applicable
    Location
    Gunma University Hospital
    Maebashi, Gunma, Japan, 371-8511
    Status
    Not applicable
    Location
    Hyogo College of Medicine Hosp
    Nishinomiya, Hyōgo, Japan, 663-8501
    Status
    Not applicable
    Location
    Yokohama City Univ Medical Ctr
    Yokohama, Kanagawa, Japan, 232-0024
    Status
    Not applicable
    Location
    Nagasaki University Hospital
    Nagasaki, Nagasaki, Japan, 〒852-8102
    Status
    Not applicable
    Showing {first} - {last} of {total} Results